Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus

American Journal of Pathology

Volumn 167, Issue 2, 2005, Pages 455-463

  Greenough, Thomas C ^a   Carville, Angela ^b   Coderre, James ^a   Somasundaran, Mohan ^a   Sullivan, John L ^a   Luzuriaga, Katherine ^a   Mansfield, Keith ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE EXTRACT; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CALLITHRIX JACCHUS; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DISEASE MODEL; EVALUATION; HEART MUSCLE; HEPATITIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LIVER CELL; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LUNG PARENCHYMA; LYMPH NODE; MARMOSET; MONONUCLEAR CELL; MULTINUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIMATE; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SUPERNATANT; VIRUS REPLICATION; ANIMAL; GENETICS; HEART; INFLAMMATION; ISOLATION AND PURIFICATION; LUNG; MONKEY DISEASE; PATHOLOGY; PNEUMONIA; TISSUE DISTRIBUTION; VIROLOGY;

ANIMALS; CALLITHRIX; HEART; HEPATOCYTES; INFLAMMATION; LUNG; LYMPH NODES; MONKEY DISEASES; MYOCARDIUM; PNEUMONIA; RNA, VIRAL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TISSUE DISTRIBUTION;

EID: 25144522376     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62989-6     Document Type: Article

References (40)

1. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE: Severe acute respiratory syndrome. Clin Infect Dis 2004, 38:1420-1427
2. Peiris JS, Yuen KY, Osterhaus AD, Stohr K: The severe acute respiratory syndrome. N Engl J Med 2003, 349:2431-2441
3. Fisher DA, Lim TK, Lim YT, Singh KS, Tambyah PA: Atypical presentations of SARS. Lancet 2003, 361:1740
4. Tee AK, Oh HM, Lien CT, Narendran K, Heng BH, Ling AE: Atypical SARS in geriatric patient. Emerg Infect Dis 2004, 10:261-264
5. Hung IF, Cheng VC, Wu AK, Chan KH, Chu CM, Wong MM, Poon LL, Tse DM, Chan KS, Woo PC, Lau SK, Peiris JS, Yuen KY: Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004, 10:1550-1557
6. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454
7. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004, 203:631-637
8. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Kang W, Weng D, Liang P, Jiang S: Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004, 203:622-630
9. Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, Cai J, Li X, Kang W, Weng D, Lu Y, Wu D, He L, Yao K: The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003, 200:282-289
10. Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC: Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2005, 191:193-197
11. Ng EK, Hui DS, Chan KC, Hung EC, Chiu RW, Lee N, Wu A, Chim SS, Tong YK, Sung JJ, Tam JS, Lo YM: Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 2003, 49:1976-1980
12. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD: Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423:240
13. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003, 362:263-270
14. McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, Butler E, Zaki S, St. Claire M, Murphy B, Subbarao K: Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys. Virology 2004, 330:8-15
15. Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St. Claire M, Murphy BR, Subbarao K, Collins PL: Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004, 363:2122-2127
16. Ambrosino DM, Roberts A, Vogel L, Thomas WDJ, Babcock GJ, Greenough TC, Guarner J, Zaki S, Sullivan JL, Subbarao K: Treatment of SARS infected hamsters with human monoclonal antibody (HuMAb 201). Presented at the 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, Oct 2004, 2:2004
17. Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, Packard M, Shieh WJ, Zaki S, Murphy B: Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004, 78:3572-3577
18. Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JS, Lim W, Osterhaus AD: Virology: SARS virus infection of cats and ferrets. Nature 2003, 425:915
19. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004, 10:871-875
20. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ: A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004, 428:561-564
21. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B: Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA 2004, 101:6641-6646
22. Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J: Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 2004, 78:12672-12676
23. ter Meulen J, Bakker AB, van den Brink EN, Weverling GJ, Martina BE, Haagmans BL, Kuiken T, de Kruif J, Preiser W, Spaan W, Gelderblom HR, Goudsmit J, Osterhaus AD: Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 2004, 363:2139-2141
24. Mansfield K: Marmoset models commonly used in biomedical research. Comp Med 2003, 53:383-392
25. Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas Jr WD, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM: Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis 2005, 191:507-514
26. Ludlage E, Mansfield K: Clinical care and diseases of the common marmoset (Callithrix jacchus). Comp Med 2003, 53:369-382
27. Mansfield KG, Veazey RS, Hancock A, Carville A, Elliott M, Lin KC, Lackner AA: Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation. Am J Pathol 2001, 159:693-702
28. Hourfar MK, Roth WK, Seifried E, Schmidt M: Comparison of two real-time quantitative assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004, 42:2094-2100
29. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348:1967-1976
30. Mazzulli T, Farcas GA, Poutanen SM, Willey BM, Low DE, Butany J, Asa SL, Kain KC: Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004, 10:20-24
31. Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Liberia K, Niedrig M, Pohlmann S: S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 2004, 78:6134-6142
32. To KF, Lo AW: Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 2004, 203:740-743
33. Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas Jr WD, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV: CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA 2004, 101:15748-15753
34. Wu KL, Lu SN, Changchien CS, Chiu KW, Kuo CH, Chuah SK, Liu JW, Lin MC, Eng HL, Chen SS, Lee CM, Chen CL: Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. Am J Trop Med Hyg 2004, 71:125-128
35. Cul HJ, Tong XL, Li P, Hao YX, Chen XG, Li AG, Zhang ZY, Duan J, Zhen M, Zhang B, Hua CJ, Gong YW: Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis. World J Gastroenterol 2004, 10:1652-1655
36. Chalmers WS, Horsburgh BC, Baxendale W, Brown TD: Enhancement of FIP in cats immunised with vaccinia virus recombinants expressing CCV and TGEV spike glycoproteins. Adv Exp Med Biol 1993, 342:359-364
37. Perlman S: Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv Exp Med Biol 1998, 440:503-513
38. Olsen CW, Corapi WV, Jacobson RH, Simkins RA, Saif LJ, Scott FW: Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity. J Gen Virol 1993, 74:745-749
39. Salazar-Mather TP, Hokeness KL: Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol 2003, 16:291-306
40. Abbott DH, Barnett DK, Colman RJ, Yamamoto ME, Schultz-Darken NJ: Aspects of common marmoset basic biology and life history important for biomedical research. Comp Med 2003, 53:339-350